Mathew S Padanilam1, Asim S Ahmed2, Brad A Clark2, Joshua I Mozes3, Leonard A Steinberg2. 1. Indiana University School of Medicine, Indianapolis, Indiana, USA. 2. St. Vincent Medical Group, St. Vincent Hospital, Indianapolis, Indiana, USA. 3. St. Luke's Idaho Cardiology Associates Heart Rhythm Center, Boise, Idaho, USA.
Abstract
INTRODUCTION: The Fontan procedure, used to palliate univentricular physiology, eliminates direct venous access to the ventricle and complicates implantable cardioverter-defibrillator (ICD) placement. METHODS AND RESULTS: We describe two patients with Fontan palliation who underwent a novel transvenous approach to ICD placement. The approach uses a transvenous bipolar lead placed in a coronary sinus branch for ventricular sensing, and a defibrillation lead placed in the right atrium for atrial sensing and ventricular defibrillation. CONCLUSION: Transvenous ICD implantation is possible in some patients with an atriopulmonary Fontan. This approach avoids a redo sternotomy for epicardial leads and excludes the need for lead placement in the systemic circulation.
INTRODUCTION: The Fontan procedure, used to palliate univentricular physiology, eliminates direct venous access to the ventricle and complicates implantable cardioverter-defibrillator (ICD) placement. METHODS AND RESULTS: We describe two patients with Fontan palliation who underwent a novel transvenous approach to ICD placement. The approach uses a transvenous bipolar lead placed in a coronary sinus branch for ventricular sensing, and a defibrillation lead placed in the right atrium for atrial sensing and ventricular defibrillation. CONCLUSION: Transvenous ICD implantation is possible in some patients with an atriopulmonary Fontan. This approach avoids a redo sternotomy for epicardial leads and excludes the need for lead placement in the systemic circulation.
Authors: Magdalena Okólska; Grzegorz Karkowski; Marcin Kuniewicz; Jacek Bednarek; Jacek Pająk; Beata Róg; Jacek Łach; Jacek Legutko; Lidia Tomkiewicz-Pająk Journal: J Clin Med Date: 2022-04-01 Impact factor: 4.241